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ABSTRACT

Author: West, Alyssa, M. MS
Institution: Purdue University
Degree Received: May 2018
Title: Impact of Disinfectant Type, Concentration, and Contact Time on Bactericidal Efficacy
against Healthcare-Associated Pathogens
Committee Chair: Dr. Haley Oliver
Transmission of healthcare-associated infections caused by antibiotic- and multi-drug
resistant

(MDR)

pathogens,

(e.g.

Methicillin-resistant

Staphylococcus

aureus

(MRSA), Pseudomonas aeruginosa) are a major concern in patient care facilities. Disinfectant
usage is critical to control and prevent pathogen transmission, yet the relationships among strain,
disinfectant type, contact time, and concentration are not well-characterized. Furthermore, many
healthcare facilities use pre-wetted disinfectant towelettes for surface disinfection, as they are an
easy-to-use solution. Yet, there is a limited consensus as to whether a surface needs to remain wet
for the full label contact time after the disinfectant towelette has been used, in order for complete
efficacy to be achieved. The purpose of this study was to quantify the effect of disinfectant
concentration and contact time on the bactericidal efficacy of clinically relevant strains of S.
aureus and P. aeruginosa. Additionally, this study examined the impact of wet versus dry contact
time on bactericidal efficacy of disinfectant towelette products. Accelerated hydrogen peroxide
(AHP), quaternary ammonium compounds (Quat), and sodium hypochlorite spray products were
tested at label and reduced contact times and concentrations against four MDR P.
aeruginosa strains and four MRSA strains. Six additional EPA-registered towelette products had
complete dry time gravimetrically measured and bactericidal efficacy calculated. Both off-label
disinfectant concentrations and contact times significantly affected the efficacy of the three spray
disinfectants tested. Bactericidal efficacy varied among both MRSA and P. aeruginosa strains.
There were also determined to be significant differences in dry times among the towelette products
tested, but contact time did not have a significant effect on bactericidal efficacy.

xi
Furthermore, there was no longitudinal effect observed when a disinfectant towelette’s contact
time was extended past its defined label contact time, whether the product remained wet on the
surface or not. The quantitative disinfectant efficacy method used in this study highlights the interstrain variability that exists within a bacterial species. This study also showed there was no
additional bactericidal efficacy of EPA-registered disinfectant towelettes post-surface drying or
beyond the label contact time.
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INTRODUCTION

1.1

Healthcare-Associated Infections (HAIs) Introduction
The Center for Disease Control (CDC) estimated that 721,800 Healthcare-Associated

Infections (HAIs) occurred in the United States in 2011 1. Furthermore, the CDC estimates that
one in 25 hospital patients have a HAI on any given day 1. The overall incidence of HAIs in the
United States is estimated to have increased by 36% in the past 20 years 2. The National Healthcare
Safety Network (NHSN) is the surveillance system the CDC uses for HAIs. The NHSN, when
performing a survey, defines an HAI as an infection that was not present or incubating in the
patient on admission to the acute care setting 3. There are exceptions to this definition which
include surgical-site infections, Clostridium difficile infections, and infections related to prior
hospitalizations that occurred within a certain timeframe 3. Using the afore-mentioned definition,
a meta-analysis was performed to determine the approximate financial impact of HAIs in the
United States, in terms of inflated 2012 dollars 4. The total annual cost was determined to be $9.8
billion, with 33.7% of the cost contributed by surgical site infections 4. A point-prevalence survey
by the CDC determined that pneumonia and surgical-site infections were the most common type
of HAI overall 3.

1.1.1

Methicillin-Resistant Staphylococcus aureus (MRSA) in Healthcare
Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen commonly associated

with HAIs. MRSA can cause bloodstream infections, pneumonia, sepsis, and death. Those who
are immunocompromised, such as those individuals found in healthcare environments, are at a
higher risk for infection. A national survey done in 2011 estimated that there were 80,461 invasive
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MRSA infections in the United States 5. The cost of MRSA is approximately $4000 per case 6.
Although invasive hospital-associated invasive MRSA infections declined by 54% between 2005
and 2011, it is still a prevalent cause of HAIs 5. The prior mentioned point-prevalence survey
determined that S. aureus was the second most common pathogen causing HAIs after C. difficile
3

. Infection control practices are key to helping control and prevent transmission of hospital-

acquired MRSA 7. Full compliance with infection control methods is needed, though, in order for
the methods to work. For example, isolation precautions will not help prevent MRSA transmission
when appropriate hand hygiene is lacking as this can lead to the transfer of MRSA 7. A study done
in 2011 examined the spread of MRSA in a Neonatal Intensive Care Unit (NICU) and found that
those patients who had a nurse in common with a MRSA-infected patient were 43% more likely
to themselves become colonized with MRSA 8. A study published in 2012 performed a three-year
hand hygiene intervention at a hospital in the United States and achieved not only a 46% increase
in hand hygiene compliance but a sustained reduction in MRSA rates as well 9.

1.1.2

Pseudomonas aeruginosa in Healthcare
Pseudomonas aeruginosa is another pathogen often associated with HAIs. The CDC

estimates that around 51,000 HAIs in the United States are due to P. aeruginosa, with 13% of
those being due multi-drug resistant (MDR) strains 10. A review by Driscoll et al. determined that
Pseudomonas aeruginosa is responsible for between 13.3% and 22.6% of nosocomial infections
in hospital intensive care units

11

. P. aeruginosa can causes serious bloodstream infections and

pneumonia, which can lead to death in those with weakened immune systems. Patients on
breathing machines or recovering from surgery are at a particularly high risk

12

. As with other

HAI-causing pathogens, infection control methods in healthcare facilities help prevent the
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transmission of P. aeruginosa. P. aeruginosa is known to form biofilms and can often be found
around drains and in sources of water. A recent study published in 2014 looked at an outbreak of
P. aeruginosa that lasted for three years in a hospital 13. After multiple rounds of environmental
sampling, the aerator in a faucet was determined to be the source 13. These results are similar to
other studies that have P. aeruginosa inhabiting water filters in hospitals 14–16.

1.2

Environmental Contamination in Healthcare Facilities
Overall, infection control practices are what help to prevent transmission of HAIs

originating from many pathogens. Specifically, environmental cleaning practices are key to
helping prevent transmission of HAIs

17–19

. The role of environmental contamination in

contribution to HAIs has been well-reviewed and studied 17,18,20–25. Even when not coming in direct
contact with an infected patient, healthcare workers can acquire pathogens on their hands after
coming into contact with environmental surfaces in the facility 22. In fact, one study demonstrated
that the environment is just as likely to contaminate a healthcare worker’s hands as direct contact
with a patient 20. This is due to the potential persistence of bacteria on inanimate surfaces around
healthcare facilities. MRSA has been shown to persist on a dry inanimate surface for up to seven
months and P. aeruginosa can persist for up to 16months on a dry floor 26.
Simple surfaces such as bedside tables, walls, and floors are not the only source of
environmental contamination in healthcare facilities that can lead to HAI transmission. A study
that examined intensive care units (ICUs) found that broad, flat surfaces were significantly more
likely to be cleaned than a complex surface like a door handle 27. This agrees with results from
another study on complex surface disinfection, which found that >90% of computer keyboards
tested in a hospital were S. aureus positive 28. Non-critical surfaces and equipment in healthcare
are defined by the Spaulding scheme (the original classification method for disinfection that is still
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used currently) as those that come in contact with intact skin, and therefore require low-level
disinfection 29. Improper disinfection of a non-critical surface, though, can lead to the spread of
pathogenic organisms throughout a facility when patient care equipment is shared. For example, a
hospital environmental study performed in 2014 showed that >50% of non-critical equipment
sampled over a two year period had consistently high levels (>200 CFU) of P. aeruginosa
contamination 30.
Even with the environment being a proven reservoir for pathogens in healthcare
environments, evidence still shows lapses in healthcare environmental cleaning and disinfection
25

. A recent article published by The Joint Commission, the group that performs hospital

inspections and audits, states that noncompliance with disinfection standards for medical
equipment has been on the rise 31. A study published in 2013 examined a large childrens hospital’s
compliance with disinfecting stethoscopes 32. It was determined that baseline compliance was only
34% and after intervention, although there was a significant increase, compliance was still just 59%
32

Many articles agree that better strategies for monitoring cleanliness and training staff are needed

19

. A 2011 study evaluated three methods as ways of monitoring the cleanliness of a hospital: visual

inspection, microbiological screening, and adenosine triphosphate (ATP) bioluminescence
measurements

33

. The results of this study showed that visual inspection does not correlate to

microbial load on a surface, but microbial load did correlate to ATP bioluminescence values 33.
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1.3

Current Disinfection Standards and Guidelines
Current disinfectant guidelines have been provided by both the EPA and CDC to help direct

healthcare facilities. The latest guidelines for disinfection and sterilization in healthcare facilities
were published in 2008 by the CDC, with recommendations to use EPA-registered disinfectants
34

. Disinfectant products must undergo efficacy testing in order to be registered by the EPA.

Efficacy testing is done internally by the disinfectant manufacturer, following EPA testing
guidelines, to generate data that supports product performance claims. Efficacy testing guidelines
for disinfectants being used on environmental surfaces were updated in February 2018

35

. For

healthcare disinfectant spray products, the recommended EPA methods for efficacy testing is the
AOAC Germicidal Spray Products as Disinfectants Test

35

. A modified version of the AOAC

Germicidal Spray Products as Disinfectants Test is used for healthcare disinfectant towelette
efficacy testing

35

. This is a qualitative efficacy validation test based upon positive or negative

culture turbidity (i.e. bacteria growth)

36

. In general, for a healthcare disinfectant to be used on

hard, non-porous surfaces, the disinfectant is tested against two specific microorganism strains- S.
aureus strain ATCC 6538 and P. aeruginosa strain ATCC 15442 35. A batch of 60 carriers is tested
against three batches of the disinfectant product. It passes the test if less than three carriers are
positive for S. aureus and less than six carriers are positive for P. aeruginosa 35.

1.4

Common Healthcare Disinfectants
There are a multitude of products that have passed the EPA’s efficacy testing requirements

and are registered disinfectants. The CDC’s guidelines for disinfection previously mentioned give
a breakdown of the benefits and uses of different types of healthcare disinfectant products (based
on active ingredient) 34. How disinfectants are chosen goes back to what is known as the Spaulding
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Scheme, developed by E. H. Spaulding in the 1950s, which is still used today 37. Spaulding broke
down patient care items and equipment into three categories: critical, semi-critical, and noncritical;
equipment classifications are determined based upon what part of the body they come in contact
with and the degree of the risk of infection 37. Spaulding determined the level of disinfection that
was needed is needed depending on which category the patient care item falls in 37. The Spaulding
Scheme is still considered to be mostly valid today, although microbiological discoveries since the
development of this scheme discovered some challenges 38. Viruses and prions were not as heavily
studied and understood 1950s; therefore the scheme may require an update 38.

1.4.1

Quaternary Ammonium Compound (Quat)- based Disinfectants

Quaternary ammonium compounds (quat disinfectants) are widely used in healthcare, specifically
on noncritical surfaces such as floors and walls 34. Problems have been seen with quat-based spray
products. For example, quat compounds bind to cotton towels used for wiping, which has been
shown to lower the disinfectant’s efficacy 39,40. A recent study published in 2016 looked at how
microfiber cloths can lower the concentration of a quat disinfectant solution 39. Microfiber wipes
that were soaked in the quat disinfectant for five minutes caused the quat concentration to be
reduced by 21%

39

. Furthermore, cotton towels soaked in the same manner caused the quat

concentration to be reduced by 50% 39.

1.4.2

Improved Hydrogen Peroxide-based Disinfectants
Hydrogen peroxide-based disinfectants have been used in healthcare disinfection practices

historically due to their long-term stability and proven effectiveness

34

. The need for a product

with a shorter contact time has led to the development of improved hydrogen peroxide (IHP)
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disinfectant products. The shorter contact time is likely to lead to better compliance with label
guidance, especially in the fast-paced healthcare world. Studies have shown that IHP products
have broad-spectrum efficacy, even with a shorter contact time than typical hydrogen peroxidebased products 41–43. A recent study published in 2017 determined that aerobic plate counts were
lower on surfaces treated with IHP than the same surface treated with a standard quat-based
disinfectant 44. These results agree with a 2012 study that compared two IHP products against three
standard hydrogen peroxide products and one quat-based disinfectant

45

. The two IHP products

tested in that study were significantly more effective against MRSA than the other products tested
45

.

1.4.3

Alcohol-based Disinfectants
Alcohol-based products are normally seen in hospitals in the form of hand sanitizers, as

they lack sporicidal abilities wanted in disinfectant products and are not recommended for
disinfection of critical medical equipment 34. Furthermore alcohol-based disinfectants are known
to dry quickly and bring question as to whether full efficacy has been reached. Alcohol can be
formulated and combined with another active ingredient, such as quat, to create a product with
more opportunities for use. An alcohol plus quat disinfectant system was proven to significantly
reduce MRSA contamination on environmental surfaces in hospitals in a 2010 study by Jury et al.
46

.
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1.4.4

Sodium Hypochlorite-based Disinfectants

Hypochlorite-based disinfectants, commonly called bleach, are well-liked for having broadspectrum biocide efficacy 34. Hypochlorite-based products are less affected by water hardness, a
benefit as these products often need dilution to a usable concentration 34.

The 2010 study by Jury et al. found that while the alcohol plus quat mixture was effective, it was
not as consistently bactericidal as a 10% bleach solution 46.
Yet, a 2016 study determined that while sodium hypochlorite reduced the presence of S. aureus
dry surface biofilms by seven logs, there were survivors and residual biofilm remaining 47.

1.5

Variables that Affect Disinfectant Efficacy
There are numerous factors that can affect a disinfectant’s efficacy. These include but are

not limited to disinfectant contact time, concentration, and microorganisms being treated

48

.

Although new recommendations for disinfectant selection are periodically published, the aforementioned factors are always taken into account. An article on disinfectant selection from 1999
focused on the need to find alternatives to using glutaraldehyde, but antimicrobial activity was still
key 49. Current recommendations on how to choose a disinfectant take customer convenience and
ease of use more into account 50.

1.5.1

Soil Load and Surface Cleaning Prior to Disinfection
The CDC’s Guidelines for Disinfection indicate that cleaning is required before

disinfection, as the matter left on a surface can interfere with the disinfectant’s action and reduce
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its efficacy 34. In the fast-paced healthcare environment, though, it is not always time-effective for
a staff to clean off foreign matter before disinfecting. Additionally, determining when a surface is
“clean” is subjective and cannot be quantified without taking an environmental sample

34

.

Thorough cleaning before disinfection can reduce the initial microbial load, as well as reduce the
number of microbial spores on a surface 51.

1.5.2

Target Microorganism

Many disinfectant labels largely highlight what microorganisms that product is effective against.
Some disinfectant formulations are designed to be extremely effective against one particular
microorganisms or group (such as Gram-positive or -negative). It has been widely accepted that,
in general, Gram-positive cocci are the most susceptible to disinfectants compared to Gramnegative rods 52. This is why disinfectant labels will list specific, differing contact times depending
on the microorganism that is being targeted. For example, while one minute may be sufficient to
eliminate S. aureus from a surface, the same product may require two minutes to be effective
against P. aeruginosa.

1.5.2.1 Mixed Populations of Microorganisms
Disinfectant labels list which specific microorganisms the product is effective against. EPA
testing only require companies to perform validation testing against one strain of a given bacterial
species 53. Furthermore, current EPA validation testing does not account for mixed species cultures
35

. This study is the first known work that looked at the possibility of inter-strain differences

affecting disinfectant bactericidal efficacy 54. This work concluded that inter-strain variability of
disinfectant efficacy occurred at label and off-label testing conditions

54

.

Disinfectants in

10
healthcare settings are applied to a broad spectrum of surfaces that contain heterogeneous
populations of pathogen microorganisms. Prior studies have shown that mixed populations of
bacteria, including biofilms, are less susceptible to disinfection 55–57. A 2012 study showed that a
hospital-based mixed species biofilm consisting of Bacillus subtilis helped to protect S. aureus
from a peroxyacetic acid-based biocide 58. These results concur with prior work that showed the
synergistic effect of a biofilm consisting of a mixed bacterial population 59.

1.5.3

Disinfectant Concentration
Use of a disinfectant at the right concentration is key to proper bactericidal efficacy being

achieved 48. A study conducted by Hong et al. performed testing on the bactericidal efficacy of
three disinfectant products (with different active ingredients) at off-label concentrations 60. This
study determined that all tested products were significantly less bactericidal at concentrations less
than the defined label concentration 60. This study further determined that the sodium hypochloritebased product tested was most tolerant to the concentration changes

60

. Disinfectant labels have

defined concentrations for use, which are verified through EPA efficacy testing. Studies have
explored if these EPA validation methods truly represent “real-world conditions” 61–63. Even with
ready-to-use disinfectant products becoming more readily available, many large healthcare
facilities still buy the highly concentrated forms in bulk due to cost. Whatever tap water source is
available is usually used to dilute the concentrated disinfectant in these instances. Tap water is
known to contain contaminants and interfering substances that can interact with the disinfectant
and prevent full efficacy from being achieved

63

. Yet, the method used to verify disinfectant

efficacy requires the use of reagent-grade water to dilute a disinfectant to the proper concentration
64

.
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1.5.4

Disinfectant Contact Time
Along with concentration, the contact time listed on a disinfectant’s product label is crucial

to achieving full efficacy. Full compliance with a disinfectant label is required by the EPA for
registered disinfectants. Hong et al. also looked at the effect of reduced contact times on a product’s
bactericidal efficacy 60. All three products tested were determined to have significantly reduced
bactericidal efficacy at contact times that were less than the defined label contact times

60

.

Specifically, the quat-based disinfectant tested was most susceptible to changes in contact time;
shorter contact times led to decreased efficacy

60

. A shorter contact time, in general, is more

desirable for the fast-paced healthcare industry, as discussed in one commentary on how to choose
the ideal disinfectant 50.

1.5.4.1 Wet Contact Time Versus Dry Contact Time
There is limited consensus as to if a label contact time means a disinfectant has to remain
wet for that full period. It also becomes subjective to the user as to what is considered “wet enough”.
There have not been any peer-reviewed original research articles published that have explored
what effect wet contact versus dry contact time has on a disinfectant’s bactericidal efficacy.

1.5.5

Disinfectant Towelettes
Ready-to-use disinfectant towelettes are a popular alternative to traditional disinfectant

spray products. Disinfectant towelettes are convenient and easy to use—desirable qualities to the
healthcare industry. Disinfectant towelettes are made up of unique substrate compositions. When

12
a disinfectant manufacturer is developing a towelette, there are over 50 wiping substrates to choose
from. As previously mentioned, quat compounds can bind to wiping substrates and decrease
disinfectant efficacy 40.
The towelette’s mode of action itself contributes to reducing the microbial load on a surface.
This is demonstrated in a 2015 study, which inoculated medical devices and equipment with S.
aureus and compared the effectiveness of the disinfectant towelette to a towelette wetted with
water 65. They saw that the products tested, on average, performed equally as well as the towelette
wetted with water; in some cases the disinfectants performed worse 65. A study by Wiemken et al.
looked at disinfectant towelettes in terms of cleaning and disinfecting compliance by hospital staff
in comparison to use of standard liquid disinfectant in a bucket with a rag 66. Wiemken et al. found
that there was a significant increase in disinfectant procedure compliance when staff was given the
towelette products to use 66.
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STRAIN, DISINFECTANT, CONCENTRATION, AND
CONTACT TIME QUANTITATIVELY IMPACT DISINFECTANT
EFFICACY

2.1

Abstract
Transmission of healthcare-associated infections caused by antibiotic- and multi-drug

resistant

(MDR)

pathogens

(e.g.

Methicillin-resistant

Staphylococcus

aureus

(MRSA), Pseudomonas aeruginosa) are a major concern in patient care facilities. Disinfectant
usage is critical to control and prevent pathogen transmission, yet the relationships among strain,
disinfectant type, contact time, and concentration are not well-characterized. We hypothesized that
there would be significant differences in disinfectant efficacy among clinically relevant strains
under off-label disinfectant conditions, but there would be no differences at registered label use
concentrations and contact times. The purpose of this study was to quantify the effect of
disinfectant concentration and contact time on the bactericidal efficacy of clinically relevant
strains of S. aureus and P. aeruginosa. Accelerated hydrogen peroxide (AHP), quaternary
ammonium compounds (Quat), and sodium hypochlorite were tested at label and reduced contact
times and concentrations against four MDR P. aeruginosa strains and four MRSA strains.
Quantitative EPA method MB-25-02 was used to measure disinfectant efficacy reported as
log10 reduction. Both off-label disinfectant concentrations and contact times significantly affected
efficacy of all disinfectants tested. Bactericidal efficacy varied among MRSA and P. aeruginosa
strains. The quantitative disinfectant efficacy method used highlights the inter-strain variability
that exists within a bacterial species. It also underscores the need for a disinfectant validation
method that takes these variances into account.
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2.2

Introduction
An estimated 722,000 healthcare-associated infections (HAIs) resulted in ~75,000 deaths in

the United States in 2011 3. Methicillin-resistant Staphylococcus aureus (MRSA) is a multi-drug
resistant (MDR) pathogen that caused an estimated 55,000 healthcare-associated invasive
infections in the United States in 2014 67. Pseudomonas aeruginosa is a leading cause of hospitalacquired pneumonia and the number one cause of wound infections in burn unit patients 11. The
emergence of multi-drug and antibiotic- resistant bacteria has led to an increased effort to improve
cleaning and disinfection procedures in healthcare facilities.
Environmental contamination has been recently recognized as a contributing factor to HAIs.
A study by Bhalla et al found that healthcare workers frequently acquired nosocomial pathogens
on their hands after coming into contact with environmental surfaces 22. Another study tracked the
contamination of soft surfaces, using tracer viruses 68. This study showed that the tracer viruses
easily spread from volunteer’s hands to multiple soft surfaces around the healthcare facility

68

.

Multiple studies have also shown that healthcare-associated pathogens can persist on surfaces in
the environment for long periods of time 26,69. Therefore, proper disinfecting procedures are crucial
in helping prevent the transmission of HAIs.
The use of Environmental Protection Agency (EPA)-registered disinfectant products is
encouraged by both the CDC and EPA 51. Users of EPA-registered products must abide by the
specific concentration and contact times listed on the label in order for the disinfectant to achieve
a five-log reduction. Some disinfectants need a full 10 minutes of surface contact time for the
product to be effective. Such a long contact time can be hard to achieve in healthcare facilities due
to the time-pressured environment 51. Therefore, it is important to understand how off-label use of
EPA-registered disinfectants may affect the efficacy of the product.
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Disinfectant usage is a key part of environmental control to prevent HAI transmission in
healthcare environments. However, the relationship between disinfectant efficacy and MDR
pathogens has not been well-characterized by current disinfectant efficacy methodologies. The
objective of this study was to examine the effect of disinfectant concentration and contact time on
bactericidal efficacy against S. aureus and P. aeruginosa. We hypothesized that there would be
quantifiable differences in disinfectant efficacy among clinically relevant strains under off-label
disinfectant conditions, but there would not be significant differences among strains at defined
label use concentrations and contact times.

2.3
2.3.1

Materials and Methods
Disinfectants and bacterial strains used in this study

In this study, we evaluated the disinfectant efficacy of AHP, Quat, and sodium hypochlorite
disinfectants using EPA standard operating procedure MB-25-02 70. In this study, we used
S. aureus ATCC CRM-6538 and P. aeruginosa ATCC 15442 as control strains, as well as
four MDR P. aeruginosa strains (Table 2.2) and four MRSA strains (Table 2.1).
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Table 2.1. Characteristics of Staphylococcus aureus strains used in study
Species of
Microorganism
Methicillin-resistant
Staphylococcus
aureus
Methicillin-resistant
Staphylococcus
aureus
Methicillin-resistant
Staphylococcus
aureus
Methicillin-resistant
Staphylococcus
aureus
Staphylococcus
aureus

ATCC Strain
Name
ATCC BAA1717

PFGE
SCCmec
Type
Type
USA 300 Type IV

pvl gene

Isolation Source

Positive

Adolescent patient
with severe sepsis

ATCC BAA1761

USA 100 Type II

Negative

Human Subject

ATCC BAA1720

USA 200 Type II

Negative

Hospital acquired

ATCC BAA1754

USA 600 Type IV

Negative

Human Subject

ATCC CRM6538

-

-

Human Lesion

-

Table 2.2. Characteristics of Pseudomonas aeruginosa strains used in study
Species of
Microorganism
Pseudomonas
aeruginosa

ATCC Strain
Name
ATCC BAA-2108

Isolation Source

Pseudomonas
aeruginosa

ATCC BAA-2112

Sputum Sample, human

Pseudomonas
aeruginosa

ATCC BAA-2113

Sputum Sample, human

Pseudomonas
aeruginosa

ATCC BAA-2114

Sputum Sample, human

Pseudomonas
aeruginosa

ATCC 15442

Animal room water bottle

Sputum Sample, human

Antibiotic
Resistance
AMX, AMP, CFZ,
CXM, CAE, CTX,
FOX, IPM, NIT,
TGC, and TMP
AMX, AMP, CFZ,
CLO, CXM, CAE,
CTX, FOX, CRO,
NIT, TGC, and TMP
AMX, AMP, CFZ,
CLO, CXM, CAE,
CTX, FOX, CRO,
NIT, TGC, and TMP
AMX, AMP, TZP,
CFZ, CLO, CXM,
CAE, CTX, FOX,
CRO, NIT, TGC,
and TMP
-
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Oxivir 1 (EPA 70627-56, Diversey Inc., Charlotte, NC) was selected to represent AHP
disinfectants; it contained 0.5% hydrogen peroxide. The Quat-based disinfectant used was
Virex Tb (EPA 76027-24, Diversey Inc., Charlotte, NC), which contained 0.105%
dimethyl benzyl ammonium chloride and 0.105% dimethyl ethyl benzyl ammonium
chloride. Avert (EPA 70627-75, Diversey Inc., Charlotte, NC) contained 1.2% sodium
hypochlorite. All three disinfectants were packaged at ready-to-use concentrations. The
disinfectant label contact time was one minute for Oxivir 1 and three minutes for Virex TB.
The disinfectant label contact time for Avert as a sporicidal agent against Clostridium
difficile was four minutes, but as a bactericidal agent the label contact time was one minute;
Avert was tested at both label contact times at label concentration.
Briefly, stainless steel coupons were inoculated with a soil load composed of 67.3%
bacterial culture, 8.7% yeast, 19.2% mucin, and 4.8% bovine serum albumin. Each
disinfectant was applied to inoculated coupons at a defined concentration and contact time;
the surviving bacterial load was recovered after application of neutralizing buffer.
Recovered bacteria were filtered onto 0.2 µm pore membrane disc filters subsequently
plated onto tryptic soy agar; colonies were counted after incubation at 37°C for 24-48 h.
2.3.2

Bactericidal efficacy of disinfectants at label use, reduced concentrations, and reduced
contact times

To determine the effect of concentration on bactericidal efficacy, three disinfectant
concentrations (50%, 75%, and 100% of label concentrations) with a constant contact time
of one minute for Oxivir 1, three minutes for Virex Tb, and four minutes for Avert were
measured. Disinfectants were at ready-to-use concentrations and were diluted using hard
water (according to EPA protocol) to reach lower concentration levels. Experiments were
performed using stainless steel coupons at approximately 22°C. Each organism and
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concentration combination consisted of three disinfectant-treated coupons (technical
replicates) and four phosphate buffered saline (PBS)-treated control coupons. The same set
of controls was used when testing two disinfectants against the same organism with the
same variable treatment. Each treatment was independently repeated three times for Oxivir
1 and Avert and five times for Virex Tb. A prior study by Hong et al. found that this method
is more variable for Quat-based disinfectants, thus more replicates were conducted to
minimize potential error 60. Bactericidal efficacy was measured at four disinfectant contact
times (30 seconds, 1 minute, 2 minutes, and 3 minutes) at label concentration to determine
the effect of varying disinfectant contact times. To determine the reduction of bacteria in
every strain, time, and concentration permutation, the log10 bacterial count of each
experimental treatment was compared to the corresponding control bacterial counts
(control coupons were exposed to PBS instead of the disinfectant).
2.3.3

Statistical Analysis
Statistical Analysis System (SAS) (version 9.4, SAS Institute Inc., Cary, NC) was

used for all analyses. All data were transformed to log10 reduction values for analyses. All
replicates were run independently for each disinfectant. One-way ANOVA was used to
determine if, under label use conditions, bacterial strain type was significantly correlated
to log10 reduction values (α= 0.05). Tukey Honest Significant Difference (HSD) test was
used to determine strain-specific differences. A generalized linear mixed model (GLMM)
was used to assess the impact of off-label contact time, concentration, and their interactions
for each disinfectant independently (α=0.05). Bacterial strain type was considered a
random variable to determine the effect of contact time and concentration on disinfectant
efficacy irrespective of strain type. An additional GLMM was used to determine specific
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differences in log10 reduction among strains exposed to each disinfectant; least squares
means with Holm-Tukey adjustment for multiple comparisons were used to determine
significant differences among the strains at off-label conditions (α=0.05).

2.4
2.4.1

Results
Disinfectant usage at label conditions has varied impact on bactericidal efficacy among
strains
Overall, there were significant differences in disinfectant efficacy at label conditions

among strains of both P. aeruginosa and MRSA (ANOVA with Tukey HSD; P=0.0132 and
P<0.0001), respectively (Figure 2.1A). Virex Tb, at label conditions, was significantly less
effective against MRSA ATCC BAA-1720 and BAA-1717 compared to all other MRSA strains
tested (P<0.05). Virex Tb was significantly more effective against P. aeruginosa strain ATCC
BAA-2114 than the control P. aeruginosa strain (P<0.05).
There were no significant differences among MRSA strains at the bactericidal (one min)
label contact time (Figure 2.1B). At sporicidal label contact time (four min), there were significant
differences in disinfectant efficacy among the strains (Figure 2.1C). The S. aureus control strain
and MRSA ATCC BAA-1720 both had significantly higher disinfectant susceptibility compared
to MRSA ATCC BAA-1754 (ANOVA with Tukey HSD; P<0.05). Avert had a significantly higher
disinfectant efficacy against P. aeruginosa ATCC BAA-2108 compared to all other P. aeruginosa
strains at bactericidal contact time (P<0.05). There were no significant differences in disinfectant
efficacy among the P. aeruginosa strains at sporicidal contact time.
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There was a significant difference in disinfectant efficacy among the strains of P.
aeruginosa (ANOVA with Tukey HSD; P=0.023) (Figure 2.1D). Specifically, Oxivir 1 was more
effective against P. aeruginosa ATCC BAA-2113 than the P. aeruginosa control strain (P<0.05).
There were no significant differences in disinfectant efficacy among MRSA strains at label
conditions.

Figure 2.1 Log10 reduction values of each bacterial strain for a given disinfectant used at label
conditions.
Letters above bars indicate statistical grouping and significant differences among strains. Graph
A: Bactericidal efficacy of Virex Tb (Quat-based) against various MRSA and P. aeruginosa
strains at label conditions (three-minute contact time). Graph B: Bactericidal efficacy of Avert
(Chlorine-based) against various MRSA and P. aeruginosa strains at bactericidal label
conditions (one minute contact time). Graph C: Bactericidal efficacy of Avert (Chlorine-based)
against various MRSA and P. aeruginosa strains at C. difficile sporicidal label conditions (fourminute contact time). Graph D: Bactericidal efficacy of Oxivir 1 (AHP-based) against various
MRSA and P. aeruginosa strains at label conditions (one minute contact time).
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2.4.2

Reduced disinfectant concentrations have varied effects on bactericidal efficacy among
strains.
Disinfectant concentration had an overall significant effect on the efficacy of Virex Tb

(GLMM; P<0.0001). The interaction between strain and disinfectant concentration was also
significant (P<0.0001). Virex Tb was more effective against MRSA ATCC BAA-1761 than both
MRSA ATCC BAA-1717 and BAA-1754 (P<0.0001) (Figure 2.2A). Virex Tb was significantly
more effective against P. aeruginosa ATCC BAA-2114 than P. aeruginosa ATCC BAA-2108
(GLMM with Holm-Tukey Correction; Padj<0.0001), P. aeruginosa ATCC BAA-2113
(Padj=0.0078), and the control strain (Padj<0.0001) at varying disinfectant concentration (Figure
2.2B).
Overall, disinfectant concentration significantly affected the efficacy of Avert (GLMM; P=
0.0209). Specifically, concentrations less than defined label use resulted in increased recovery of
bacteria. Avert was significantly more effective against the S. aureus control strain than MRSA
ATCC BAA-1717 (GLMM with Holm-Tukey Correction; Padj=0.0434) and MRSA ATCC BAA1754 (Padj<0.0001) at varying disinfectant concentrations (Figure 2.2C). Avert was also
significantly more effective against P. aeruginosa ATCC BAA-2108 than the control strain
(Padj=0.0029), P. aeruginosa ATCC BAA-2112 (Padj=0.0015), P. aeruginosa ATCC BAA-2113
(Padj<0.0001), and P. aeruginosa ATCC BAA-2114 (Padj=0.0257) under varying disinfectant
concentrations (Figure 2.2D).
Disinfectant concentration had a significant effect on the efficacy of Oxivir 1 (P=0.0027).
There was no significant difference in disinfectant efficacy with varying disinfectant
concentrations among MRSA strains (Figure 2.2E). Oxivir 1 was significantly more effective
against P. aeruginosa ATCC BAA-2112 (GLMM with Holm-Tukey Correction; Padj= 0.0105), P.
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aeruginosa ATCC BAA-2113 (Padj<0.0001), P. aeruginosa ATCC BAA-2114 (Padj= 0.0051) than
the control strain at varying disinfectant concentrations (Figure 2.2F). Oxivir 1 was significantly
less effective against P. aeruginosa ATCC BAA-2108 (Padj<0.0001) than P. aeruginosa ATCC
BAA-2112, BAA-2113, and BAA-2114 at varying disinfectant concentrations (Figure 2.2F).
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Figure 2.2 Effect of varying disinfectant concentration on the bactericidal efficacy of three
disinfectants at label concentration
Panel A: Bactericidal efficacy of Virex Tb (Quat-based) against various MRSA strains. Panel
B: Bactericidal efficacy of Virex Tb (Quat-based) against various P. aeruginosa strains. Panel
C: Bactericidal efficacy of Avert (Chlorine-based) against various MRSA strains. Panel D:
Bactericidal efficacy of Avert (Chlorine-based) against various P. aeruginosa strains. Panel E:
Bactericidal efficacy of Oxivir 1 (AHP-based) against various MRSA strains. Panel F:
Bactericidal efficacy of Oxivir 1 (AHP-based) against various P. aeruginosa strains.
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2.4.3

Reduced disinfectant contact times have varied effects on bactericidal efficacy among
strains.
Disinfectant contact time had an overall significant effect on the efficacy of Virex Tb

(GLMM; P<0.0001). The interaction between strain and disinfectant contact time was also
significant (P<0.0001). Virex Tb was significantly more effective against the control S. aureus
strain than MRSA ATCC BAA-1717 (GLMM with Holm-Tukey Correction; Padj<0.0001), MRSA
ATCC BAA-1720 (Padj=0.0007), and MRSA ATCC BAA-1754 (Padj=0.0372) at varying
disinfectant contact times (Figure 2.3A). The disinfectant was also more effective against MRSA
ATCC BAA-1761 than both MRSA ATCC BAA-1717 and BAA-1754 (P<0.0001) (Figures 2.3A).
Virex Tb was significantly more effective against P. aeruginosa ATCC BAA-2114 than P.
aeruginosa ATCC BAA-2112 (Padj=0.0001), P. aeruginosa ATCC BAA-2113 (Padj=0.0155), and
the control strain (Padj<0.0001), at varying disinfectant contact times (Figure 2.3B).
Avert was significantly more effective against MRSA ATCC BAA-1717 (Padj=0.0215)
and MRSA ATCC BAA-1720 (Padj=0.0035) than MRSA ATCC BAA-1754 at varying disinfectant
contact times (Figure 2.3C). Avert was significantly more effective against P. aeruginosa ATCC
BAA-2108 than the other four P. aeruginosa ATCC strains (GLMM with Holm-Tukey Correction;
all Padj<0.0001) (Figure 2.3D).
Overall, disinfectant contact time (GLMM; P= 0.0328) had a significant effect on the
efficacy of Oxivir 1. Oxivir 1 was significantly more effective against MRSA ATCC BAA-1754
than MRSA ATCC BAA-1720 (Padj=0.0099) and BAA-1761 (Padj=0.0008) (Figure 2.3E). Oxivir
1 was significantly more effective against P. aeruginosa ATCC BAA-2108 (Padj=0.0081) and P.
aeruginosa ATCC BAA-2114 (Padj=0.0015) than the control strain at varying disinfectant contact
times (Figure 2.3F).
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Figure 2.3. Effect of varying disinfectant contact time on bactericidal efficacy of three
disinfectants at label concentration
Panel A: Bactericidal efficacy of Virex Tb (Quat-based) against various MRSA strains. Panel B:
Bactericidal efficacy of Virex Tb (Quat-based) against various P. aeruginosa strains. Panel C:
Bactericidal efficacy of Avert (Chlorine-based) against various MRSA strains. Panel D:
Bactericidal efficacy of Avert (Chlorine-based) against various P. aeruginosa strains. Panel E:
Bactericidal efficacy of Oxivir 1 (AHP-based) against various MRSA strains. Panel F:
Bactericidal efficacy of Oxivir 1 (AHP-based) against various P. aeruginosa strains.
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2.5

Discussion
In this study, we tested three disinfectants under label and off-label use condition on strains

with varying antibiotic resistance profiles using EPA method MB-25-02 70. Using this quantitative
EPA method, we found significant, quantifiable differences in disinfectant efficacy among strains
of S. aureus and P. aeruginosa at label and off-label use conditions and that these differences
varied by disinfectant.
2.5.1

There are significant differences in disinfectant efficacy among strains tested under labeluse conditions.
We found significant differences among strains at disinfectant label use conditions; the

results varied based on disinfectant. For example, Virex Tb (quat-based) was significantly less
effective against MRSA ATCC BAA-1720 yet Avert (chlorine-based) was significantly more
effective at sporicidal conditions against the strain. Differences among strains were observed for
all disinfectants at label-use conditions. Current EPA testing methods to register a healthcare
disinfectant (for use on hard non-porous surfaces) requires testing against the two control strains
used in this study 35; it does not evaluate different strains. One of the specific testing methods that
can be used for registering disinfectants is AOAC Use-Dilution method 64. Positive and negative
results are determined through a visual inspection for the presence or absence of turbidity
(indicating microbial growth). The AOAC Use-Dilution method is qualitative, whereas the method
used in this study (MB 25-02) is quantitative. Our data suggest that further research is warranted
to determine if the disinfectant efficacy testing for EPA registration should be re-evaluated to
include multiple strains.
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2.5.2

Efficacy of reduced concentration and contact time is strain dependent.
Overall, our results showed that disinfectant efficacy varied by strain under off-label

conditions. Our data showed that off-label use of a disinfectant product does lead to reduced
efficacy. Per United States federal law regarding EPA-registered products, all applicable label
instructions must be followed for proper disinfectant use and to achieve full efficacy 34. A review
by Schabrun and Chipchase in 2006 noted that “equipment used in the non-critical setting is less
likely to have standard cleaning protocols than equipment used in the critical setting” 71. A study
by Davis looked at blood pressure cuffs as a potential source of cross-contamination in hospitals
72

. This study concluded that that these non-critical medical devices needed more vigilant

disinfection procedures and called into question if the time-constrained emergency nurses were
best suited for the disinfection role

72

. Furthermore, the CDC’s Guidelines for Disinfection and

Sterilization in Healthcare Facilities notes numerous factors that may influence a disinfectant’s
contact time or concentration, and therefore efficacy

34

. Using disinfectants to clean complex

medical devices can be challenging. It can be difficult to expose the internal channels of a medical
device to the disinfectant for the label contact time, especially as internal air pockets will interfere
with this process

34

. In this study, we used disinfectants at ready-to-use concentrations.

Concentrated products are common and are typically diluted with water; water hardness can reduce
disinfection efficacy. Efficacy can be lowered by the formation of insoluble precipitates due to the
presence of divalent cations in hard water 34. Neither the AOAC Use-Dilution Testing method or
the EPA method we used in this study take this real-world problem into account. Both methods
use specially prepared water that won’t interfere with the disinfectant efficacy testing 64,70.
Although our study highlighted the importance of disinfectant contact time and
concentration to achieve efficacy, it is still not well-defined what level of efficacy is needed for a
healthcare environment to be considered hygienic. EPA Standard Operating Procedures are very
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specific on the soil level, surface type, and bacterial strains to be used when doing efficacy testing.
This makes it difficult to translate efficacy from lab testing to actual environmental disinfection.
This study was limited to ten strains as well, warranting more work to be done.

2.6

Conclusion
In this study, we found differences in disinfectant efficacy amongst strains at label and off-

label conditions. Further, we found that concentration and contact time significantly affect
disinfectant efficacy of three disinfectants in different ways. The consequences of off-label use of
disinfectants is demonstrated in this study. This study underscores the variability of disinfectant
efficacy within a bacterial genus. Our data suggests additional strains and additional test methods
should be investigated to better understand inter-strain variability.
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SURFACES DAMAGED BY DISINFECTANTS DO NOT
HAVE AN INCREASED MICROBIAL RISK

3.1

Abstract
Environmental cleaning practices are key to helping prevent the transmission of healthcare-

associated infections. Surfaces can become damaged, though, after prolonged exposure to
disinfectants used in environmental cleaning. The objective of this study was to determine if the
survival rate for Staphylococcus aureus, after exposure to various disinfectants, is impacted by
carrier surface damage. This study used a modified version of EPA method MB-25-02 on three
damaged surfaces: Formica, polycarbonate, and low-density polyethylene. There were no
significant differences in disinfectant efficacy between the undamaged and damaged surfaces, for
all of the surface types tested.

3.2

Introduction

An estimated 722,000 healthcare-associated infections (HAIs) resulted in ~75,000 deaths in the
United States in 2011 3. In healthcare settings, environmental cleaning practices are key to
preventing the transmission of HAIs. Disinfectants are frequently used in environmental cleaning
as part of the regular sanitation plan. With continued disinfectant use, the risk of damage to the
surface is subjective to several influences. The age of the surface, exposure time, chemical
composition of the disinfectant, and method of disinfectant application all attribute to potential
damage to common surfaces

73

. The CDC’s Guidelines for Disinfection and Sterilization in

Healthcare Facilities lists the shortcomings of various disinfection chemicals, as well as what
kinds of surfaces they can cause damage to
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. As a functional reality, these guidelines are not

always properly executed, and disinfectants are used on surfaces they are not intended for.
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An article by Spaulding in 1964 reviewed alcohol as a disinfectant and shows that alcohol
has been known to damage certain materials

74

. Another publication notes that corrosion of

stainless steel (a material often found in healthcare environments) by disinfectants can often cause
damage that is not visible to the naked eye 73. Even so, this damage can provide a place for bacteria
to inhabit and grow 73. Repeated use of a disinfectant on a damaged surface will only exacerbate
the damage and create a wider berth for bacteria to inhabit 73. Although it has been known for some
time that repeated exposure of a surface to a disinfectant can cause surface damage, the effect on
disinfectant efficacy has not been quantified. The objective of this study was to evaluate the
microbial risk of surfaces damaged by disinfectants. We hypothesized that the survival rate for
bacterial pathogens after disinfectant use will be greater on a surface damaged by repeated
disinfectant use.

3.3

Materials and Methods
In this study we evaluated the disinfectant efficacy of a Quat-based disinfectant using a

modified version of EPA standard operating procedure MB-25-02 70. Briefly, bacterial culture was
mixed with a soil load (yeast, mucin, and BSA) and inoculated onto 1”x1” coupons of the test
surfaces. The coupons were desiccated for one hour to adhere the bacteria to the surface. The
disinfectant was then applied to the coupons and left to sit for the label contact time. After the
contact time was reached, 10 mL of neutralizing buffer was added, and the coupon was vortexed
in the neutralizing buffer. The solution was vacuum-filtered onto a filter membrane to recover any
bacteria that were left. The membrane filter was plated onto TSA for 24-48 h. at 37°C, and colonies
were counted.
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3.3.1

Surface Damage of Materials
Three surface materials were tested in this study: polycarbonate, low-density

polyethylene (LDPE), and Formica. Each surface underwent two different types of
disinfectant damage. The surfaces were wiped with the disinfectant four times (twice in
each direction) and allowed to air dry for 10 minutes. This was repeated 200 times, to
simulate six months of exposure to the disinfectant. Another set of the surfaces were
immersed in the disinfectant solution for four weeks at room temperature, to simulate
extreme exposure. For each surface material, an undamaged sample was tested to establish
a baseline of disinfectant efficacy.

3.3.2

Efficacy Testing of Disinfectants

The Quat-based disinfectant used was Virex II 256 (EPA 76027-24, Diversey Inc,
Charlotte, NC), which contains 8.19% alkyl dimethyl benzyl ammonium chloride and 8.7%
1-decanaminium, N-decyl-N, N-dimethyl-, chloride. The concentrated disinfectant was
diluted at 1:256 using hard water, following EPA MB-25-02

70

. The disinfectant label

contact time was 10 minutes, and five biological replicates were done for each surfacedisinfectant combination. The bacteria tested was Staphylococcus aureus (ATCC #6538),
the standard test microbe used in EPA MB-25-02 70.
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3.3.3

Statistical Analyses

Statistical Analysis Software (SAS), version 9.4, was used to perform analysis of the data.
All data were transformed to log10 reduction values for analysis. One-way ANOVA with
Tukey Honest Significant Difference (HSD) test was used to determine if differences in
disinfectant efficacy existed between the three surface treatments (α=0.05).

3.4
3.4.1

Results and Discussion
Disinfectant efficacy was not significantly affected by surface damage

On average, the disinfectant achieved a 3.16 log10 reduction on the undamaged surfaces.
Specifically, Virex II 256 achieved an average 3.26 log10 reduction on wiped LDPE and an
average 3.68 log10 reduction on immersed LDPE (Figure 3.1). Statistical analysis determined that
there was not a significant difference in bactericidal efficacy between the undamaged, wiped, and
immersed LDPE surfaces (P>0.05). Virex II 256 achieved an average 2.88 log10 reduction on
wiped Formica and an average 3.29 log10 reduction on immersed Formica (Figure 3.1). There
was no significant difference in disinfectant efficacy between the undamaged, wiped, and
immersed Formica surfaces (P>0.05). Virex II 256 achieved an average 2.97 log10 reduction on
wiped polycarbonate and an average 3.29 log10 reduction on immersed polycarbonate (Figure
3.1).
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Figure 3.1 Log10 reduction values of S. aureus for Virex II 256 (Quat-based disinfectant) on
three polymer surfaces

3.5

Conclusion

The EPA testing method used in this study may not be sensitive enough to detect the differences
in disinfectant efficacy, due to surface damage. Future work could be done using a different EPA
testing method, to see if any of the EPA testing methods are sensitive enough to detect efficacy
differences. Also, the surfaces tested may not have been damaged enough for a difference in
efficacy to be seen. The chemically-induced damage, done by disinfectants, in this study did not
seem to have any impact on disinfectant efficacy.
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THERE IS NO ADDITIONAL BACTERICIDAL
EFFICACY OF EPA-REGISTERED DISINFECTANT TOWELETTES
POST-SURFACE DRYING OR BEYOND LABEL CONTACT TIME

4.1

Abstract
Transmission of healthcare-associated infections (HAIs) is a significant concern in patient

care facilities. Proper cleaning and disinfection of environmental surfaces and patient care
equipment is key to preventing transmission of microorganisms causing HAIs. Disinfectant
towelettes are an easy-to-use solution for surface disinfection in healthcare settings. The
disinfectant is pre-applied to the towelette, eliminating the need to determine how much
disinfectant needs to be applied to the surface. Yet, there is a limited consensus as to whether a
surface needs to remain wet for the full label contact time after the disinfectant towelette has been
used, in order for complete efficacy to be achieved. We hypothesized that disinfectants that dry
before the label contact time is reached would have reduced efficacy. We further hypothesized that
there would be no additional kill occurring after the time point at which the disinfectant dried on
the surface. The purpose of this study was to quantify the effect of disinfectant to contact time on
the bactericidal efficacy of six EPA registered towelette products. Six EPA registered disinfectant
towelette products were tested at varying contact times, including defined label contact time.
Quantitative EPA method MB-33-00 was used to measure disinfectant efficacy reported as log10
reduction on Formica.
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Complete dry time for each disinfectant was gravimetrically measured. There were
significant differences in dry times among the towelette products, but contact time did not have a
significant effect on bactericidal efficacy. Furthermore, there was no longitudinal effect observed
when a disinfectant’s contact time was extended past its defined label contact time, whether the
product remained wet on the surface or not. This study showed there was no additional bactericidal
efficacy of EPA-registered disinfectant towelettes post-surface drying or beyond the label contact
time.

4.2

Introduction
Healthcare-associated infections (HAIs) are estimated to affect hundreds of millions of

patients around the world every year 75. In 2011 it was estimated that there were 721,800 HAIs in
United States acute care hospitals 3. A study that analyzed 1,022 HAI outbreaks determined that
two of the most frequent sources of the infections were medical equipment or devices 76. Many
studies have shown than the environment contributes to these infections and that pathogenic
microorganisms can be transferred from gloved hands without direct patient contact 20,22,77. Proper
cleaning and disinfection of environmental surfaces and patient care equipment is an important
element in preventing the transmission of HAI-related microorganisms. This can be accomplished
through the use of disinfectant towelettes, which provide an easy, ready-to-use version of
traditional sprays. This is especially important for efficiency in fast-paced healthcare environments.
However, there is increasing evidence that there are significant lapses in procedures and quality of
healthcare cleaning and disinfection, despite the presence of institutional policies consistent with
national guidance

78

. These can include not leaving the disinfectant on the surface for the full

contact time listed on the label 50,79. There are conflicting viewpoints on the impact of wet contact
time on disinfectant efficacy. Some published works indicate that surfaces must remain wet for
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the full disinfection contact time to achieve the sufficient bactericidal efficacy 50,79–81. Alternatively,
a recently published commentary by Rutala and Weber indicated that wet contact time is not
necessary for disinfectant towelette products to meet Environmental Protection Agency (EPA)
efficacy requirements 82. A white paper by Clayton also agreed with this claim 83. Overall there is
no consensus among disinfectant manufacturers as to the impact of wet contact time on bactericidal
efficacy 81–84. Furthermore, there have been no peer-reviewed studies conducted to our knowledge
that specifically investigate the impact of wet versus dry contact time on bactericidal efficacy using
EPA methodology. The objective of this study was to better understand the relationship between
contact time, dry time, and efficacy of towelettes using an EPA-approved method. We
hypothesized that disinfectants that dried before the label contact time would have reduced
bactericidal efficacy. We further hypothesized that there would be no additional kill occurring after
the time point at which the disinfectant had dried on the surface.

4.3
4.3.1

Materials and Methods
Disinfectants and bacteria used in study
This study tested six disinfectant towelette products described in (Table 4.1). Diversey

EasyWipes (dry wipes) wetted with phosphate buffered saline (PBS;15.1 mL per towelette) were
used as a control. EPA standard strain Staphylococcus aureus strain ATCC CRM-6538 was used
in this study to measure towelette efficacy.
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Table 4.1. Active ingredients and contact time for towelettes tested in study
Disinfectant
Producta
0.233% quat +
14.3% alcohol
0.76% quat +
22.5% alcohol
0.25% quat

Disinfectant Active Ingredient(s)
-

0.28% quat

-

0.233% diisobutylphenoxyethoxyethyl dimethyl
benzyl ammonium chloride
14.3% isopropanol
0.76% didecyldimethylammonium chloride
7.5% ethanol
15% isopropanol
0.125% n-alkyl dimethyl ethylbenzyl ammonium
chlorides
0.125% n-alkyl dimethyl benzyl ammonium
chlorides
0.14% n-alkyl dimethyl ethylbenzyl ammonium
chlorides
0.14% n-alkyl dimethyl benzyl ammonium
chlorides
0.55% sodium hypochlorite

Label Contact
Timeb
3 min

1 min

3 min

3 min

0.55% sodium
30 s
hypochlorite
1.4% hydrogen - 1.4% hydrogen peroxide
1 min
peroxide
a
This naming scheme was used to identify the disinfectant on towelettes throughout the study;
b

Defined label contact time for S. aureus.
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4.3.2

Drying time method
Six by six inch Formica squares were used to perform the dry testing. Briefly, the Formica

square was pre-weighed on a Mettler-Toledo AG204 analytical balance (Mettler-Toledo LLC,
Columbus, OH) (accurate to 0.0001 g). For disinfectant application, the first towelette from the
disinfectant container was thrown away and the second one was used to ensure the tested towelette
was fully wet. The surface was wiped with consistent pressure, from left to right, in four passes
back and forth. The weight of the Formica square was recorded starting at t = 0 s and every 15 s
thereafter until the weight did not change for at least one min, indicating the square was dry. Dry
time testing was completed independently five times for each disinfectant product and the PBS
control.

4.3.3

Towelette efficacy testing method
A modified version of EPA SOP MB-33-00 (QPM for Determining the Effectiveness of

Antimicrobial Towelettes Against Vegetative Bacteria on Inanimate, Hard, Non-porous Surfaces)
was used to evaluate towelette efficacy on inoculated 97mm diameter Formica discs

85

. The

Formica discs were disinfected in 100% ethanol for one minute prior to inoculation with a soil
load composed of 67.3% bacterial culture, 19.2% mucin, 8.7% yeast, and 4.8% bovine serum
albumin. Inoculated discs were dried in a 37°C incubator for approximately 25 min to adhere the
bacteria to the surface. Following EPA SOP MB-33-00, the Formica was wiped with a disinfectant
towelette and the discs were left to sit for a pre-determined contact time. Ten contact times were
tested: 30 s, 1 min, 2 min, 3 min, 4 min, 5 min, 10 min, 20 min, 30 min, and 60 min. After the
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contact time was reached, the discs were swabbed with a PUR-Blue Swab Sampler (World
Bioproducts, Libertyville, IL) containing 10 mL of neutralizing buffer. The swab samplers were
vortexed to release the bacteria and the solution vacuum-filtered onto a filter membrane following
the EPA protocol 85. Membrane filters were plated on TSA, incubated for 24-48 h at 37°C, then
enumerated. Five biological replicates were conducted for quat-based products and three
biological replicates for all others. Three technical replicates were performed within each
biological replicate.

4.3.4

Statistical analyses
Statistical Analysis System (SAS) (version 9.4, SAS Institute Inc., Cary, NC) was

used for all analyses. A generalized linear model (GLM) was generated for total dry time
values. Least squares means with Tukey-Kramer adjustment for multiple comparisons was
used to determine if there was a significant difference in disinfectant total drying time
among the products tested (α=0.05). Disinfectant efficacy data were transformed into
log10 reduction values for all analyses. A generalized linear mixed model (GLMM) was
used to determine if the disinfectant product, contact time, or variable interaction had a
significant impact on disinfectant efficacy (α=0.05). Least squares means with TukeyKramer adjustment for multiple comparisons was used to determine if there were
significant differences in efficacy among disinfectant products. One-way ANOVA was
used to determine if there were significant differences in bactericidal efficacy between
defined label contact time and calculated dry time (α=0.05).
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Means analysis with Tukey’s Studentized Range (HSD) Test was used to determine if there
was a significant difference in log10 reduction values between the defined label contact
time, the calculated dry time, and each extended contact time point tested.

4.4
4.4.1

Results
Disinfectant dry time significantly varied among products tested.
Five of the six products tested remained wet until the label contact time was reached.

However, the 0.28% quat product (Figure 4.1A) dried at two min and 45 s under these test
conditions; it has a label contact time of three min. Furthermore, the 0.25% quat product (Figure
4.1B) and 1.4% hydrogen peroxide product (Figure 4.1C) remained wet 10 s less than the label
contact time.
There were significant differences among the times it took for the disinfectant to fully dry.
The 0.233% quat + 14.3% alcohol product (Figure 4.1D) had a significantly longer drying time
compared to the 0.76% quat + 22.5% alcohol (GLMM with Tukey-Kramer Correction; Padj=0.0005)
(Figure 4.1E), 0.25% quat (Padj=0.0057), 0.28% quat products (Padj<0.0001), and 1.4% hydrogen
peroxide (Padj<0.0001). The 0.55% sodium hypochlorite product (Figure 4.1F) had a significantly
longer drying time compared to the 0.76% quat + 22.5% alcohol (Padj=0.0398), 1.4% hydrogen
peroxide (Padj=0.0002), and 0.28% quat products (Padj=0.0025). The 1.4% hydrogen peroxide
product had a significantly longer drying time compared to the 0.25% quat product (Padj=0.0398).
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Figure 4.1. Drying time curve based on surface wetness after application of disinfectant
Drying time curve based on surface wetness, by weight measurements, after application of
disinfectant for six disinfectant products. Bold vertical line indicates label contact time point for
each product. Dashed vertical line indicates the time point at which the disinfectant was
determined to be fully dry. Panel A: Drying time curve for 0.28% quat product. Panel B:
Drying time curve for 0.25% quat product. Panel C: Drying time curve for 1.4% hydrogen
peroxide product. Panel D: Drying time curve for 0.233% quat +14.3% alcohol. Panel E:
Drying time curve for 0.76% quat + 22.5% alcohol product. Panel F: Drying time curve for
0.55% sodium hypochlorite product.
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4.4.2

Disinfectant mode of action had a significant effect on bactericidal efficacy.
Overall, there were significant differences in bactericidal efficacy among products, which

all had different modes of action (GLMM; P<0.0001). Contact time and the interaction between
contact time and product were not significant. Overall, the 0.28% quat product (Figure 4.2A)
achieved a significantly higher log10 reduction compared to the 0.76% quat + 22.5% alcohol
product (Padj<0.0001). The 0.233% quat + 14.3% alcohol achieved a significantly higher
bactericidal efficacy compared to the 0.25% quat (Padj=0.0148) (Figure 4.2B). The 1.4% hydrogen
peroxide product (Figure 4.2C) also achieved a significantly higher log10 reduction than the 0.25%
quat (Padj=0.0145) and the 0.76% quat+ 22.5% alcohol products (Padj<0.0001). The 0.233% quat
+ 14.3% alcohol (Figure 4.2D) achieved a significantly higher log10 reduction as compared to
0.76% quat+ 22.5% alcohol (Figure 4.2E) (GLMM with Tukey-Kramer Correction; Padj<0.0001).
The 0.55% sodium hypochlorite product (Figure 4.2F) achieved a significantly higher log10
reduction as compared to the 0.25% quat product (Padj<0.0001) and the 0.76% quat+ 22.5% alcohol
product (Padj<0.0001). The PBS-wetted control towelettes achieved an approximate three log10
reduction in bacteria overall. Only four of the six products tested had significantly higher
bactericidal efficacy compared to the control towelette wetted with PBS (all Padj<0.05). The 0.25%
quat product and the 0.76% quat + 22.5% alcohol product did not achieve significantly different
log10 reduction values compared to wiping with a PBS-wetted towelette.
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Figure 4.1. Bactericidal efficacy of six disinfectant products with varying contact times.
Bactericidal efficacy, based on Log10 reduction values, of six different disinfectant products
with varying contact times. Ten contact time points were tested for each product. Panel A:
Bactericidal efficacy of a 0.28% quat product over time. Panel B: Bactericidal efficacy of a
0.25% quat product over time. Panel C: Bactericidal efficacy of a 1.4% hydrogen peroxide
product over time. Panel D: Bactericidal efficacy of a 0.233% quat +14.3% alcohol product over
time. Panel E: Bactericidal efficacy of a 0.76% quat +22.5% alcohol product over time. Panel
F: Bactericidal efficacy of 0.55% sodium hypochlorite disinfectant product over time.
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4.4.3

Bactericidal efficacy did not significantly change after product was dry on surface or
after label contact time was reached.
There was no significant difference in bactericidal efficacy at defined label contact time and

calculated dry time for all products tested. This included the 0.28% quat product, which dried
before its label contact time was reached. Specifically, there were no significant differences
between the log10 reduction at the time point when the disinfectant dried and each time point
tested thereafter (Means comparison with Tukey HSD; Padj>0.05). It was also determined that there
were no significant differences in log10 reduction at the disinfectant label contact time and each
time point tested after defined label contact time (Means comparison with Tukey HSD; Padj>0.05).

4.5

Discussion
In this study we tested six disinfectant towelette products to determine the impact of dry time

and contact time on bactericidal efficacy, using EPA method MB-33-00 85. We found significant
differences in the time it took each product to fully dry on Formica surfaces. We also found that
bactericidal efficacy varied among the products tested, although label contact time did not impact
efficacy. There are limited peer reviewed studies on disinfectant towelette performance and, to
our knowledge, this work is among the first quantitative investigations to evaluate the impact of
dry time on efficacy.

4.5.1

Disinfectant mode of action, not contact time, significantly affected bactericidal efficacy
It was determined that disinfectant mode of action, not contact time, was a significant

variable. During dry testing the 0.28% quat product dried before its label contact time was reached.
This could be due to the presence of other inactive ingredients, as other quat-based products tested
did not dry before the label contact time was reached. While the product dried before the defined
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label contact time, contact time did not impact the bactericidal efficacy. These findings contradict
the conclusion that wet contact time is crucial for complete disinfection of a surface 50. Our study
was limited to testing one S. aureus strain; therefore, we cannot definitively say that wet contact
time doesn’t have a significant impact.
Overall, the 0.55% sodium hypochlorite product achieved the highest bactericidal efficacy
and the 0.76% quat + 22.5% alcohol product was the least effective against S. aureus at defined
label concentration and contact time. Four of the six products tested had significantly higher
bactericidal efficacy compared to the control towelette wetted with PBS. The 0.25% quat and the
0.76% quat + 22.5% alcohol products did not achieve a significantly higher log10 reduction than
the control towelette wetted with PBS. The disinfectant towelettes tested in this study were
composed of multiple substrates, thus we cannot rule out that the towelettes themselves impacted
bactericidal efficacy. There are over 50 wiping substrates available to disinfectant manufacturers
to select from when developing a disinfectant towelette product. Substrate selection has been
shown to be extremely important for quat-based products; certain substrate types will bind with
the quat compounds, preventing full efficacy from occurring

23,86

. Therefore, further research is

needed to determine the extent of the effect towelette composition has on a disinfectant’s
bactericidal efficacy.

4.6

No additive bactericidal effect beyond the dry time and the label contact time
We found that the disinfectant towelettes did not achieve any statistically significant

additional kill after the disinfectant dry time or label contact was reached using a quantitative
method. The 0.55% sodium hypochlorite product’s bactericidal efficacy reached the detection
limit (approx. five log reduction) in this study, thus we cannot definitively assess the longitudinal
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effect of 0.55% sodium hypochlorite under these conditions. A recently published commentary
paper by Rutala and Weber concluded that a surface does not need to remain wet for the full label
contact time of a disinfectant towelette product in order for bactericidal efficacy to be achieved 82.
A white paper recently published by a disinfectant towelette manufacturer concluded the same as
the afore mentioned paper 83. Clayton stated that “the EPA does not require test surfaces to remain
wet during the test method [for registration]” and “regardless of whether the surface is wet, dry, or
somewhere in between, the efficacy is assured to be in line with the EPA registration”

83

.

Furthermore, the current EPA registration testing method referenced in both papers is qualitative;
the testing method used in this study quantified bactericidal efficacy 83. Sans an exception noted
in Clayton, EPA does not explicitly state in the testing protocol that the surface must remain visibly
wet 87. The exception is the testing procedure for Clostridium difficile and Candida auris sporicide
towelette products. This guidance document states: “A determination for the amount of time the
carrier remains wet should be made. This wetness determination will be used to generate the
contact time”

35

. The EPA is advising all pesticide registrants that the contact time should be

shorter than the time the surface remains wet irrespective of target organism 88. Furthermore, the
EPA is recommending that disinfectant manufacturers conduct visual and gravimetric wetness
tests (although they are not required to do so) 88.
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4.7

Conclusion
Overall, in this study we found differences in disinfectant efficacy among products with

different modes of action, which was not influenced by label contact time. Further, we found that
there was no additional bactericidal efficacy, of EPA-registered disinfectant towelettes, achieved
post-surface drying or beyond label contact time. Our data highlight the effect of dry time on
disinfectant efficacy and underscore the need for consistent language and guidance on wet
contact time.
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